LONGITUDINAL advances development of its clinical trial decision intelligence platform

LONGITUDINAL is continuing to develop its approach for translating continuous wearable data into clearer clinical trial insight.

The work is being shaped by expert input, analysis of clinical studies enabled by wearables and engagement with clinical trial workflow specialists. A consistent theme is emerging: wearable and connected devices are creating new opportunities in clinical development, but the value is only realised when continuous data can support better operational and clinical decisions.

LONGITUDINAL’s focus remains on building a practical approach, relevant to trial workflows, that helps CROs and pharma sponsors move from data capture to insight that supports earlier action by trial teams.